Skip to main content
. 2020 Oct 13;6(3):e001290. doi: 10.1136/rmdopen-2020-001290

Figure 1.

Figure 1

Factors significantly associated with satisfaction with efficacy of treatment after 1 year of treatment. Shown are adjusted ORs with 95% CIs. bDMARD, biological disease-modifying antirheumatic drug; BMI, body mass index; DAS28-ESR, Disease Activity Score in 28 joint-erythrocyte sedimentation rate.